JP2016525343A5 - - Google Patents

Download PDF

Info

Publication number
JP2016525343A5
JP2016525343A5 JP2016517056A JP2016517056A JP2016525343A5 JP 2016525343 A5 JP2016525343 A5 JP 2016525343A5 JP 2016517056 A JP2016517056 A JP 2016517056A JP 2016517056 A JP2016517056 A JP 2016517056A JP 2016525343 A5 JP2016525343 A5 JP 2016525343A5
Authority
JP
Japan
Prior art keywords
antibody
seq
sequence
antibiotic
conjugate compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016517056A
Other languages
English (en)
Japanese (ja)
Other versions
JP6469094B2 (ja
JP2016525343A (ja
Filing date
Publication date
Priority claimed from PCT/US2014/039113 external-priority patent/WO2014193722A1/en
Priority claimed from US14/284,609 external-priority patent/US20140356375A1/en
Application filed filed Critical
Priority claimed from PCT/US2014/040324 external-priority patent/WO2014194247A1/en
Publication of JP2016525343A publication Critical patent/JP2016525343A/ja
Publication of JP2016525343A5 publication Critical patent/JP2016525343A5/ja
Application granted granted Critical
Publication of JP6469094B2 publication Critical patent/JP6469094B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016517056A 2013-05-31 2014-05-30 抗細胞壁タイコ酸抗体及びコンジュゲート Expired - Fee Related JP6469094B2 (ja)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US201361829466P 2013-05-31 2013-05-31
US201361829461P 2013-05-31 2013-05-31
US61/829,461 2013-05-31
US61/829,466 2013-05-31
USPCT/US2014/039113 2014-05-22
PCT/US2014/039113 WO2014193722A1 (en) 2013-05-31 2014-05-22 Anti-wall teichoic antibodies and conjugates
US14/284,609 2014-05-22
US14/284,609 US20140356375A1 (en) 2013-05-31 2014-05-22 Anti-wall teichoic antibodies and conjugates
PCT/US2014/040324 WO2014194247A1 (en) 2013-05-31 2014-05-30 Anti-wall teichoic antibodies and conjugates

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2018208440A Division JP2019054801A (ja) 2013-05-31 2018-11-05 抗細胞壁タイコ酸抗体及びコンジュゲート

Publications (3)

Publication Number Publication Date
JP2016525343A JP2016525343A (ja) 2016-08-25
JP2016525343A5 true JP2016525343A5 (enExample) 2018-06-14
JP6469094B2 JP6469094B2 (ja) 2019-02-13

Family

ID=51989438

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2016517056A Expired - Fee Related JP6469094B2 (ja) 2013-05-31 2014-05-30 抗細胞壁タイコ酸抗体及びコンジュゲート
JP2018208440A Pending JP2019054801A (ja) 2013-05-31 2018-11-05 抗細胞壁タイコ酸抗体及びコンジュゲート

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2018208440A Pending JP2019054801A (ja) 2013-05-31 2018-11-05 抗細胞壁タイコ酸抗体及びコンジュゲート

Country Status (30)

Country Link
EP (2) EP3381939A1 (enExample)
JP (2) JP6469094B2 (enExample)
KR (1) KR20160015227A (enExample)
CN (2) CN105358573B (enExample)
AU (2) AU2014273939B2 (enExample)
BR (1) BR112015029838A2 (enExample)
CA (1) CA2910029A1 (enExample)
CL (1) CL2015003496A1 (enExample)
CR (1) CR20150626A (enExample)
DK (1) DK3004162T3 (enExample)
EA (1) EA201592078A1 (enExample)
ES (1) ES2793174T3 (enExample)
HK (1) HK1220982A1 (enExample)
HR (1) HRP20200812T1 (enExample)
HU (1) HUE050451T2 (enExample)
IL (1) IL242175B (enExample)
LT (1) LT3004162T (enExample)
MA (1) MA38686A1 (enExample)
MX (2) MX369022B (enExample)
MY (1) MY177774A (enExample)
PE (1) PE20160715A1 (enExample)
PH (1) PH12015502636A1 (enExample)
PL (1) PL3004162T3 (enExample)
PT (1) PT3004162T (enExample)
RS (1) RS60256B1 (enExample)
SG (1) SG11201509839TA (enExample)
SI (1) SI3004162T1 (enExample)
UA (1) UA120088C2 (enExample)
WO (1) WO2014194247A1 (enExample)
ZA (1) ZA201507977B (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112015029754A2 (pt) 2013-05-31 2017-09-26 Genentech Inc anticorpos anti-teicoico da parede e conjugados
UA118113C2 (uk) 2013-12-16 2018-11-26 Дженентек, Інк. Пептидоміметичні сполуки та їх кон'югати антитіла з лікарським засобом
KR102337414B1 (ko) 2013-12-16 2021-12-10 제넨테크, 인크. 펩타이드 모방체 화합물 및 이의 항체-약물 컨쥬게이트
HRP20241124T1 (hr) * 2014-09-11 2024-11-22 Seagen Inc. Ciljana isporuka lijekovitih tvari koje sadrže tercijarni amin
KR20170086536A (ko) 2014-12-03 2017-07-26 제넨테크, 인크. 항-스타필로코커스 아우레우스 항체 리파마이신 접합체 및 이의 용도
JP6751393B2 (ja) 2014-12-03 2020-09-02 ジェネンテック， インコーポレイテッド 抗ｓｔａｐｈｙｌｏｃｏｃｃｕｓ ａｕｒｅｕｓ抗体リファマイシン抱合体及びその使用
MX2017007169A (es) * 2014-12-03 2018-05-02 Genentech Inc Compuestos de amina cuaternaria y conjugados de anticuerpofármaco de los mismos.
US10017577B2 (en) 2015-06-15 2018-07-10 Genentech, Inc. Antibodies and immunoconjugates
US11793880B2 (en) 2015-12-04 2023-10-24 Seagen Inc. Conjugates of quaternized tubulysin compounds
TWI852735B (zh) 2015-12-04 2024-08-11 美商思進公司 四級胺化妥布賴森(tubulysin)化合物之結合物
CN108713020A (zh) * 2016-03-04 2018-10-26 豪夫迈·罗氏有限公司 制备抗体-利福霉素缀合物的方法
KR20190005998A (ko) * 2016-05-18 2019-01-16 젠맵 비. 브이 항체 및 감염성 질환의 치료에서의 그의 사용 방법
US10639378B2 (en) 2016-06-06 2020-05-05 Genentech, Inc. Silvestrol antibody-drug conjugates and methods of use
CN111601803A (zh) 2017-09-08 2020-08-28 西雅图基因公司 微管溶素及其中间体的制备方法
US11857638B2 (en) 2018-07-27 2024-01-02 Promega Corporation Quinone-containing conjugates
WO2021195716A1 (en) * 2020-04-02 2021-10-07 Monash University Antibiotic conjugates
GB202214756D0 (en) * 2022-10-07 2022-11-23 Univ Oxford Innovation Ltd Product

Family Cites Families (70)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB877732A (en) 1958-08-12 1961-09-20 Lepetit Spa The antibiotic rifomycin, its components and methods of preparing same
US3773919A (en) 1969-10-23 1973-11-20 Du Pont Polylactide-drug mixtures
US4485045A (en) 1981-07-06 1984-11-27 Research Corporation Synthetic phosphatidyl cholines useful in forming liposomes
US4867973A (en) * 1984-08-31 1989-09-19 Cytogen Corporation Antibody-therapeutic agent conjugates
DD266710A3 (de) 1983-06-06 1989-04-12 Ve Forschungszentrum Biotechnologie Verfahren zur biotechnischen Herstellung van alkalischer Phosphatase
US4544545A (en) 1983-06-20 1985-10-01 Trustees University Of Massachusetts Liposomes containing modified cholesterol for organ targeting
US4879231A (en) 1984-10-30 1989-11-07 Phillips Petroleum Company Transformation of yeasts of the genus pichia
US4737456A (en) 1985-05-09 1988-04-12 Syntex (U.S.A.) Inc. Reducing interference in ligand-receptor binding assays
US4610919A (en) 1985-06-14 1986-09-09 Fiber Bond Corporation Binder for fibrous padding
GB8610600D0 (en) 1986-04-30 1986-06-04 Novo Industri As Transformation of trichoderma
JP2544375B2 (ja) 1986-07-14 1996-10-16 鐘淵化学工業株式会社 アルキル置換ベンゾキサジノリフアマイシン誘導体
IL85035A0 (en) 1987-01-08 1988-06-30 Int Genetic Eng Polynucleotide molecule,a chimeric antibody with specificity for human b cell surface antigen,a process for the preparation and methods utilizing the same
CA1304363C (en) 1988-11-01 1992-06-30 Takehiko Yamane 3'-hydroxybenzoxazinorifamycin derivative, process for preparing the same and antibacterial agent containing the same
EP0402226A1 (en) 1989-06-06 1990-12-12 Institut National De La Recherche Agronomique Transformation vectors for yeast yarrowia
US5013556A (en) 1989-10-20 1991-05-07 Liposome Technology, Inc. Liposomes with enhanced circulation time
ATE255131T1 (de) 1991-06-14 2003-12-15 Genentech Inc Humanisierter heregulin antikörper
US5362852A (en) 1991-09-27 1994-11-08 Pfizer Inc. Modified peptide derivatives conjugated at 2-hydroxyethylamine moieties
US6660267B1 (en) 1992-12-21 2003-12-09 Promega Corporation Prevention and treatment of sepsis
US5545721A (en) 1992-12-21 1996-08-13 Ophidian Pharmaceuticals, Inc. Conjugates for the prevention and treatment of sepsis
US6214345B1 (en) 1993-05-14 2001-04-10 Bristol-Myers Squibb Co. Lysosomal enzyme-cleavable antitumor drug conjugates
US6214388B1 (en) 1994-11-09 2001-04-10 The Regents Of The University Of California Immunoliposomes that optimize internalization into target cells
US5981522A (en) 1995-09-01 1999-11-09 Kaneka Corporation Treatment of disease caused by infection of Helicobacter
JP3963976B2 (ja) 1995-12-08 2007-08-22 株式会社カネカ クラミジア感染症治療剤
US6322788B1 (en) * 1998-08-20 2001-11-27 Stanley Arthur Kim Anti-bacterial antibodies and methods of use
PT1176195E (pt) 1999-04-09 2013-07-18 Kyowa Hakko Kirin Co Ltd Processo para controlar a actividade de uma molécula funcional sob o ponto de vista imunológico
CA2373221A1 (en) 1999-05-03 2000-11-30 Yashwant M. Deo Human antibodies to staphylococcus aureus
CA2388245C (en) 1999-10-19 2012-01-10 Kyowa Kirin Co., Ltd. The use of serum-free adapted rat cells for producing heterologous polypeptides
US7064191B2 (en) 2000-10-06 2006-06-20 Kyowa Hakko Kogyo Co., Ltd. Process for purifying antibody
DK2314686T4 (da) 2000-10-06 2023-08-21 Kyowa Kirin Co Ltd Celler, der danner antistofsammensætninger
US6946292B2 (en) 2000-10-06 2005-09-20 Kyowa Hakko Kogyo Co., Ltd. Cells producing antibody compositions with increased antibody dependent cytotoxic activity
US6884869B2 (en) 2001-04-30 2005-04-26 Seattle Genetics, Inc. Pentapeptide compounds and uses related thereto
US7091186B2 (en) 2001-09-24 2006-08-15 Seattle Genetics, Inc. p-Amidobenzylethers in drug delivery agents
WO2003026577A2 (en) 2001-09-24 2003-04-03 Seattle Genetics, Inc. P-amidobenzylethers in drug delivery agents
KR100988949B1 (ko) 2001-10-25 2010-10-20 제넨테크, 인크. 당단백질 조성물
JP2005511627A (ja) 2001-11-20 2005-04-28 シアトル ジェネティクス，インコーポレーテッド 抗ｃｄ３０抗体を使用する免疫学的疾患の治療
US20040093621A1 (en) 2001-12-25 2004-05-13 Kyowa Hakko Kogyo Co., Ltd Antibody composition which specifically binds to CD20
AU2003236020B2 (en) 2002-04-09 2009-03-19 Kyowa Hakko Kirin Co., Ltd. Cell with depression or deletion of the activity of protein participating in GDP-fucose transport
US20040259150A1 (en) 2002-04-09 2004-12-23 Kyowa Hakko Kogyo Co., Ltd. Method of enhancing of binding activity of antibody composition to Fcgamma receptor IIIa
AU2003236017B2 (en) 2002-04-09 2009-03-26 Kyowa Kirin Co., Ltd. Drug containing antibody composition
US20040110704A1 (en) 2002-04-09 2004-06-10 Kyowa Hakko Kogyo Co., Ltd. Cells of which genome is modified
EP1502603A4 (en) 2002-04-09 2006-12-13 Kyowa Hakko Kogyo Kk AN ANTIBODY COMPOSITION CONTAINING MEDICAMENT FOR PATIENTS WITH Fc gamma RIIIa POLYMORPHISM
CA2481837A1 (en) 2002-04-09 2003-10-16 Kyowa Hakko Kogyo Co., Ltd. Production process for antibody composition
ES2544527T3 (es) 2002-07-31 2015-09-01 Seattle Genetics, Inc. Conjugados de fármacos y su uso para tratar el cáncer, una enfermedad autoinmune o una enfermedad infecciosa
EP1575514A2 (en) 2002-07-31 2005-09-21 Seattle Genetics, Inc. Anti-cd20 antibody-drug conjugates for the treatment of cancer and immune disorders
US7217797B2 (en) 2002-10-15 2007-05-15 Pdl Biopharma, Inc. Alteration of FcRn binding affinities or serum half-lives of antibodies by mutagenesis
CA2502413A1 (en) 2002-11-01 2004-05-21 The Regents Of The University Of Colorado, A Body Corporate Quantitative analysis of protein isoforms using matrix-assisted laser desorption/ionization time of flight mass spectrometry
JP2006514636A (ja) * 2002-12-02 2006-05-11 バイオシネクサス インコーポレーテッド 抗ブドウ球菌療法およびワクチンの標的としての壁テイコイン酸
EP1944320A1 (en) 2002-12-16 2008-07-16 Genentech, Inc. Immunoglobulin variants and uses thereof
EP1663107A4 (en) 2003-08-22 2010-06-23 Activbiotics Pharma Llc RIFAMYCIN ANALOGS AND USES THEREOF
AU2004279742A1 (en) 2003-10-08 2005-04-21 Kyowa Hakko Kirin Co., Ltd. Fused protein composition
JPWO2005035778A1 (ja) 2003-10-09 2006-12-21 協和醗酵工業株式会社 α１，６−フコシルトランスフェラーゼの機能を抑制するＲＮＡを用いた抗体組成物の製造法
EP3434275A1 (en) * 2003-11-06 2019-01-30 Seattle Genetics, Inc. Assay for cancer cells based on the use of auristatin conjugates with antibodies
JPWO2005053742A1 (ja) 2003-12-04 2007-06-28 協和醗酵工業株式会社 抗体組成物を含有する医薬
WO2005062882A2 (en) 2003-12-23 2005-07-14 Activbiotics, Inc Rifamycin analogs and uses thereof
EP1718667B1 (en) 2004-02-23 2013-01-09 Genentech, Inc. Heterocyclic self-immolative linkers and conjugates
ES2579805T3 (es) 2004-09-23 2016-08-16 Genentech, Inc. Anticuerpos y conjugados modificados por ingeniería genética con cisteína
WO2007008848A2 (en) 2005-07-07 2007-01-18 Seattle Genetics, Inc. Monomethylvaline compounds having phenylalanine carboxy modifications at the c-terminus
JP5171621B2 (ja) 2005-07-07 2013-03-27 シアトル ジェネティックス， インコーポレイテッド フェニルアラニン側鎖修飾をｃ末端に有するモノメチルバリン化合物
EP1928890B1 (en) * 2005-08-11 2013-04-03 Targanta Therapeutics Inc. Phosphonated rifamycins and uses thereof for the prevention and treatment of bone and joint infections
CN101395259A (zh) 2005-12-14 2009-03-25 活跃生物药物学有限公司 利福霉素类似物及其应用
JP5669397B2 (ja) 2007-03-01 2015-02-12 シムフォゲン・アクティーゼルスカブＳｙｍｐｈｏｇｅｎ Ａ／Ｓ 同族抗体をクローニングするための方法
TW200902554A (en) 2007-05-08 2009-01-16 Genentech Inc Cysteine engineered anti-MUC16 antibodies and antibody drug conjugates
AU2008312457B2 (en) 2007-10-19 2014-04-17 Genentech, Inc. Cysteine engineered anti-TENB2 antibodies and antibody drug conjugates
AU2009246510B2 (en) 2008-05-12 2014-02-13 Strox Biopharmaceuticals, Llc Staphylococcus aureus-specific antibody preparations
US8524691B2 (en) 2008-08-13 2013-09-03 The Medicines Company Phosphonated rifamycins and uses thereof for the prevention and treatment of bone and joint infections
WO2010042481A1 (en) 2008-10-06 2010-04-15 University Of Chicago Compositions and methods related to bacterial eap, emp, and/or adsa proteins
TR201809128T4 (tr) * 2009-07-15 2018-07-23 Aimm Therapeutics Bv Gram-pozitif bakterilere spesifik bağlanan bileşikler.
SG185428A1 (en) 2010-06-08 2012-12-28 Genentech Inc Cysteine engineered antibodies and conjugates
ES2531471T3 (es) 2011-02-25 2015-03-16 Lonza Ltd Enlazador ramificado para conjugados de proteínas-fármacos
WO2013168965A2 (ko) * 2012-05-07 2013-11-14 목암생명공학연구소 포도상구균 감염 예방용 백신 조성물

Similar Documents

Publication Publication Date Title
WO2023078021A1 (en) Bcma monoclonal antibody and the antibody-drug conjugate
RU2015151046A (ru) Антитела против стеночной тейхоевой кислоты и их конъюгаты
RU2017118793A (ru) Конъюгаты антитела к staphylococcus aureus с рифамицином и их применение
JP2018503603A5 (enExample)
RU2017118792A (ru) Конъюгаты антитела к staphylococcus aureus с рифамицином и их применение
CN109912683B (zh) 一种细胞毒素分子、偶联物及其制备方法和应用
CN113423430B (zh) 含支链连接子的鹅膏毒素偶联物
JP2018507166A5 (enExample)
KR20230034957A (ko) 캄프토테신 유사체를 갖는 세포-결합 분자의 접합체
HRP20200812T1 (hr) Protutijela protiv teihonske kiseline staničnog zida i konjugati
HRP20221280T1 (hr) Spojevi i njihovi konjugati
TW202108179A (zh) 細胞毒性劑經由支鏈連接子與細胞結合分子的偶聯物
JP2017528418A5 (enExample)
CN111093707A (zh) 含支链连接体的Tubulysin同系物偶联物
CN116143678A (zh) 偶联连接体，含有此连接体的细胞结合分子-药物偶联物及其制备和应用
EP3086814A1 (de) Binder-konjugate (adcs) mit ksp-inhibitoren
AU2016202632A1 (en) Specific conjugation linkers, specific immunoconjugates thereof, methods of making and uses such conjugates thereof
CN112272669A (zh) 横交联吡咯并苯二氮杂*二聚体（pbd）衍生物及其偶联物
RU2016129894A (ru) Ковалентно связанные конъюгаты хеликар-антитело против хеликара и их применения
CN110279872A (zh) 细胞毒素分子同细胞结合受体分子的共轭体
WO2024239281A1 (en) Targeted treatment of prostate cancers and other tumors by an antibody-drug conjugate
TWI923934B (zh) Ｂｃｍａ 單株抗體及抗體藥物結合物
EA053258B1 (ru) Конъюгат аматоксинового аналога с разветвленными линкерами
HRP20201293T1 (hr) Citotoksični derivati benzodiazepina
EA048944B1 (ru) Сшитое производное димера пирролобензодиазепина (pbd) и его конъюгаты